166 related articles for article (PubMed ID: 12417394)
1. Clinical and non-clinical investigations using positron emission tomography, near infrared spectroscopy and transcranial Doppler methods on the neuroprotective drug vinpocetine: a summary of evidences.
Vas A; Gulyás B; Szabó Z; Bönöczk P; Csiba L; Kiss B; Kárpáti E; Pánczél G; Nagy Z
J Neurol Sci; 2002 Nov; 203-204():259-62. PubMed ID: 12417394
[TBL] [Abstract][Full Text] [Related]
2. [Human positron emission tomography with oral 11C-vinpocetine].
Vas A; Christer H; Sóvágó J; Johan S; Cselényi Z; Kiss B; Kárpáti E; Lars F; Gulyás B
Orv Hetil; 2003 Nov; 144(46):2271-6. PubMed ID: 14702922
[TBL] [Abstract][Full Text] [Related]
3. [Cerebral uptake and metabolism of (11C) Vinpocetine in monkeys: PET studies].
Gulyás B; Halldin C; Karlsson P; Chou YH; Swahn CG; Bönöczk P; Farde L
Orv Hetil; 1999 Jul; 140(30):1687-91. PubMed ID: 10461449
[TBL] [Abstract][Full Text] [Related]
4. PET studies on the brain uptake and regional distribution of [11C]vinpocetine in human subjects.
Gulyás B; Halldin C; Sandell J; Karlsson P; Sóvágó J; Kárpáti E; Kiss B; Vas A; Cselényi Z; Farde L
Acta Neurol Scand; 2002 Dec; 106(6):325-32. PubMed ID: 12460136
[TBL] [Abstract][Full Text] [Related]
5. Role of sodium channel inhibition in neuroprotection: effect of vinpocetine.
Bönöczk P; Gulyás B; Adam-Vizi V; Nemes A; Kárpáti E; Kiss B; Kapás M; Szántay C; Koncz I; Zelles T; Vas A
Brain Res Bull; 2000 Oct; 53(3):245-54. PubMed ID: 11113577
[TBL] [Abstract][Full Text] [Related]
6. Asymptomatic ischemic cerebrovascular disorders and neuroprotection with vinpocetine.
Hadjiev D
Ideggyogy Sz; 2003 May; 56(5-6):166-72. PubMed ID: 12861957
[TBL] [Abstract][Full Text] [Related]
7. Drug distribution in man: a positron emission tomography study after oral administration of the labelled neuroprotective drug vinpocetine.
Gulyás B; Halldin C; Sóvágó J; Sandell J; Cselényi Z; Vas A; Kiss B; Kárpáti E; Farde L
Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1031-8. PubMed ID: 12173017
[TBL] [Abstract][Full Text] [Related]
8. Effects of vinpocetine on the redistribution of cerebral blood flow and glucose metabolism in chronic ischemic stroke patients: a PET study.
Szilágyi G; Nagy Z; Balkay L; Boros I; Emri M; Lehel S; Márián T; Molnár T; Szakáll S; Trón L; Bereczki D; Csiba L; Fekete I; Kerényi L; Galuska L; Varga J; Bönöczk P; Vas A; Gulyás B
J Neurol Sci; 2005 Mar; 229-230():275-84. PubMed ID: 15760651
[TBL] [Abstract][Full Text] [Related]
9. Vinpocetine increases cerebral blood flow and oxygenation in stroke patients: a near infrared spectroscopy and transcranial Doppler study.
Bönöczk P; Panczel G; Nagy Z
Eur J Ultrasound; 2002 Jun; 15(1-2):85-91. PubMed ID: 12044859
[TBL] [Abstract][Full Text] [Related]
10. Brain uptake and plasma metabolism of [11C]vinpocetine: a preliminary PET study in a cynomolgus monkey.
Gulyás B; Halldin C; Karlsson P; Chou YH; Swahn CG; Bönöck P; Paróczai M; Farde L
J Neuroimaging; 1999 Oct; 9(4):217-22. PubMed ID: 10540601
[TBL] [Abstract][Full Text] [Related]
11. [Cerebral uptake and regional distribution of [11C]-vinpocetin after intravenous administration to healthy men: a PET study].
Vas A; Sóvágó J; Halldin C; Sandell J; Karlsson P; Kárpáti E; Kiss B; Cselényi Z; Farde L; Gulyás B
Orv Hetil; 2002 Nov; 143(47):2631-6. PubMed ID: 12532649
[TBL] [Abstract][Full Text] [Related]
12. Cerebral effects of a single dose of intravenous vinpocetine in chronic stroke patients: a PET study.
Szakáll S; Boros I; Balkay L; Emri M; Fekete I; Kerényi L; Lehel S; Márián T; Molnár T; Varga J; Galuska L; Trón L; Bereczki D; Csiba L; Gulyás B
J Neuroimaging; 1998 Oct; 8(4):197-204. PubMed ID: 9780850
[TBL] [Abstract][Full Text] [Related]
13. Cerebral uptake of [ethyl-11C]vinpocetine and 1-[11C]ethanol in cynomolgous monkeys: a comparative preclinical PET study.
Gulyás B; Vas A; Halldin C; Sóvágó J; Sandell J; Olsson H; Fredriksson A; Stone-Elander S; Farde L
Nucl Med Biol; 2002 Oct; 29(7):753-9. PubMed ID: 12381455
[TBL] [Abstract][Full Text] [Related]
14. [The role of vinpocetine in the treatment of cerebrovascular diseases based in human studies].
Bagoly E; Fehér G; Szapáry L
Orv Hetil; 2007 Jul; 148(29):1353-8. PubMed ID: 17631470
[TBL] [Abstract][Full Text] [Related]
15. [Investigation of the effect of vinpocetine on cerebral blood flow and cognitive functions].
Valikovics A
Ideggyogy Sz; 2007 Jul; 60(7-8):301-10. PubMed ID: 17713111
[TBL] [Abstract][Full Text] [Related]
16. [The effect of a single-dose intravenous vinpocetine on brain metabolism in patients with ischemic stroke].
Gulyás B; Bönöczk P; Vas A; Csiba L; Bereczki D; Boros I; Szakáll S; Balkay L; Emri M; Fekete I; Galuska L; Kerényi L; Lehel S; Márián T; Molnár T; Varga J; Trón L
Orv Hetil; 2001 Mar; 142(9):443-9. PubMed ID: 11301903
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of Vinpocetine as Part of Treatment for Acute Cerebral Infarction: A Randomized, Open-Label, Controlled, Multicenter CAVIN (Chinese Assessment for Vinpocetine in Neurology) Trial.
Zhang W; Huang Y; Li Y; Tan L; Nao J; Hu H; Zhang J; Li C; Kong Y; Song Y
Clin Drug Investig; 2016 Sep; 36(9):697-704. PubMed ID: 27283947
[TBL] [Abstract][Full Text] [Related]
18. Eburnamine derivatives and the brain.
Vas A; Gulyás B
Med Res Rev; 2005 Nov; 25(6):737-57. PubMed ID: 16158388
[TBL] [Abstract][Full Text] [Related]
19. Role of vinpocetine in cerebrovascular diseases.
Patyar S; Prakash A; Modi M; Medhi B
Pharmacol Rep; 2011; 63(3):618-28. PubMed ID: 21857073
[TBL] [Abstract][Full Text] [Related]
20. Visualising neuroinflammation in post-stroke patients: a comparative PET study with the TSPO molecular imaging biomarkers [11C]PK11195 and [11C]vinpocetine.
Gulyas B; Toth M; Vas A; Shchukin E; Kostulas K; Hillert J; Halldin C
Curr Radiopharm; 2012 Jan; 5(1):19-28. PubMed ID: 22074478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
